ABIVAX reports the number of shares and voting rights as of March 31, 2024

The company ABIVAX announced, in its report dated April 30, 2024, the figures relating to the number of shares making up its share capital and the total number of voting rights as of March 31, 2024. This information comes from a communication mandatory regulation, in accordance with the provisions of article L. 233-8 II of the commercial code and article 223-16 of the general regulations of the Financial Markets Authority.

Located in Paris, ABIVAX is a public limited company with a share capital of 629,288.18 euros. It is registered under the number Paris B 799 363 718. As of March 31, 2024, the company had a total of 62,928,818 shares. The number of theoretical voting rights amounted to 69,929,576, while the number of exercisable voting rights reached 69,918,480.